Morgan Stanley Starts Syndax Pharmaceuticals (SNDX) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
JMP Securities Starts Syndax Pharmaceuticals (SNDX) at Market Outperform
March 28, 2016 8:36 AM EDTJMP Securities initiated coverage on Syndax Pharmaceuticals (NASDAQ: SNDX) with a Market Outperform rating and a price target of $28.00.
For an analyst ratings summary and ratings history on Syndax Pharmaceuticals click here. For more ratings news on Syndax Pharmaceuticals click here.
Shares of Syndax Pharmaceuticals closed at $12.62 yesterday.
... More